These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 4201309

  • 1. Formulation of three nitrosoureas for intravenous use.
    Davignon JP, Yang KW, Wood HB, Cradock JC.
    Cancer Chemother Rep 3; 1973 May; 4(3):7-11. PubMed ID: 4201309
    [No Abstract] [Full Text] [Related]

  • 2. Nitrosoureas in central nervous system tumors.
    Walker MD.
    Cancer Chemother Rep 3; 1973 May; 4(3):21-6. PubMed ID: 4584033
    [No Abstract] [Full Text] [Related]

  • 3. Current status of new agents.
    Carter SK.
    Cancer Chemother Rep 3; 1972 May; 3(1):33-47. PubMed ID: 4116662
    [No Abstract] [Full Text] [Related]

  • 4. 3-(Tetraacetyl glucopyranos-2-yl)-1-(2-chloroethyl)-1-nitrosourea, an antitumor agent with modified bone marrow toxicity.
    Schein PS, McMenamin MG, Anderson T.
    Cancer Res; 1973 Sep; 33(9):2005-9. PubMed ID: 4353476
    [No Abstract] [Full Text] [Related]

  • 5. 1,3-bis(2-chloroethyl)-1-nitrosourea (bcnu) and other nitrosoureas in cancer treatment: a review.
    Carter SK, Schabel FM, Broder LE, Johnston TP.
    Adv Cancer Res; 1972 Sep; 16():273-332. PubMed ID: 4563045
    [No Abstract] [Full Text] [Related]

  • 6. Interrelationships of some chemical, physicochemical, and biological activities of several 1-(2-haloethyl)-1-nitrosoureas.
    Wheeler GP, Bowdon BJ, Grimsley JA, Lloyd HH.
    Cancer Res; 1974 Jan; 34(1):194-200. PubMed ID: 4809457
    [No Abstract] [Full Text] [Related]

  • 7. Antitumour activity of a new water-soluble nitrosoureido sugar: CY233 (NSC 609224).
    Gosse C, Atassi G, Letourneux Y, Ardouin P, Gouyette A, Fournier JP, Roger P.
    Anticancer Res; 1988 Jan; 8(6):1419-22. PubMed ID: 3218975
    [Abstract] [Full Text] [Related]

  • 8. Relationship of structure to anticancer activity and toxicity of the nitrosoureas in animal systems.
    Johnston TP, Montgomery JA.
    Cancer Treat Rep; 1986 Jan; 70(1):13-30. PubMed ID: 2935250
    [No Abstract] [Full Text] [Related]

  • 9. Therapy of advanced gastrointestinal cancer with the nitrosoureas.
    Moertel CG.
    Cancer Chemother Rep 3; 1973 May; 4(3):27-34. PubMed ID: 4748872
    [No Abstract] [Full Text] [Related]

  • 10. An overview of the status of the nitrosoureas in other tumors.
    Carter SK.
    Cancer Chemother Rep 3; 1973 May; 4(3):35-46. PubMed ID: 4584034
    [No Abstract] [Full Text] [Related]

  • 11. [On the therapy of lymphogranuloma. CCNU (1(2-chlorethyl)-3-cyclohexyl-1-nitrosourea) and BCNU (1,3-bis(2-chlorethyl)-1-nitrosourea) as well as BCNU combinations in Hodgkin's lymphogranuloma, stage 3 and 4].
    Brunner KW, Maurice P, Sonntag RW.
    Schweiz Med Wochenschr; 1972 Oct 28; 102(43):1546-51. PubMed ID: 4647016
    [No Abstract] [Full Text] [Related]

  • 12. Early history and development of the nitrosoureas.
    Schepartz SA.
    Cancer Treat Rep; 1976 Jun 28; 60(6):647-9. PubMed ID: 782693
    [No Abstract] [Full Text] [Related]

  • 13. Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
    Frei E, Schabel FM, Goldin A.
    Cancer Res; 1974 Jan 28; 34(1):184-93. PubMed ID: 4520419
    [No Abstract] [Full Text] [Related]

  • 14. Antitumor structure-activity relations. Nitrosoureas vs. L-1210 leukemia.
    Hansch C, Leo A, Schmidt C, Jow PY, Montgomery JA.
    J Med Chem; 1980 Oct 28; 23(10):1095-101. PubMed ID: 7420354
    [Abstract] [Full Text] [Related]

  • 15. Toxicology and pharmacology of the nitrosoureas.
    Oliverio VT.
    Cancer Chemother Rep 3; 1973 May 28; 4(3):13-20. PubMed ID: 4201308
    [No Abstract] [Full Text] [Related]

  • 16. Contributions of nitrosoureas to cancer treatment.
    Mitchell EP, Schein PS.
    Cancer Treat Rep; 1986 Jan 28; 70(1):31-41. PubMed ID: 3002621
    [No Abstract] [Full Text] [Related]

  • 17. Historical development and future promise of the nitrosoureas as anticancer agents.
    Schabel FM.
    Cancer Chemother Rep 3; 1973 May 28; 4(3):3-6. PubMed ID: 4584035
    [No Abstract] [Full Text] [Related]

  • 18. Synthesis and antitumour activity of several new 4-aroyl-1-nitrosohydrazinecarboxamides.
    Gugova R, Topakbashian V, Lozeva S, Dimov S, Golovinsky E.
    Drugs Exp Clin Res; 1997 May 28; 23(2):71-5. PubMed ID: 9309382
    [Abstract] [Full Text] [Related]

  • 19. Fat emulsion vehicle for intravenous administration of an aqueous insoluble drug.
    Fortner CL, Grove WR, Bowie D, Walker MD.
    Am J Hosp Pharm; 1975 Jun 28; 32(6):582-4. PubMed ID: 1155469
    [Abstract] [Full Text] [Related]

  • 20. [Experimental studies on oral administration of nitrosourea anti-tumor agent, MCNU].
    Sekido S, Ninomiya K, Araki T, Ueno M, Kinbara M.
    Gan To Kagaku Ryoho; 1984 Jul 28; 11(7):1492-500. PubMed ID: 6234861
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.